25 April, 2024 in Investor Relations Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
18 April, 2024 in Investor Relations, Videos Nexalin Technology unveils positive results of clinical study for Gen-2 tACS device
09 April, 2024 in Investor Relations Nexalin Technology Accelerates Manufacturing of its HALO™ Clarity Following Successful Usability, Feasibility, and Electrical Testing
04 April, 2024 in Investor Relations Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device
02 April, 2024 in Investor Relations Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board
